EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration

EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency
   Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring
   proceedings without self-administration

   16-Jul-2026 / 23:10 CET/CEST
   Disclosure of an inside information acc. to Article 17 MAR of the
   Regulation (EU) No 596/2014, transmitted by [1]EQS News - a service of
   [2]EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   Korneuburg, Austria, 16^th July 2026 – Marinomed Biotech AG (VSE:MARI)
   announces the plan to apply for the initiation of a court restructuring
   proceeding without self-administration. The application is being filed
   because the court-approved restructuring plan dated November 14, 2024,
   cannot be fulfilled due to the breakdown of negotiations by Unither and
   the failure of Unither Pharmaceuticals to make earn-out payments from the
   sale of the Carragelose business unit, thereby placing the company at risk
   of insolvency. The aim of the renewed restructuring proceedings without
   self-administration is to secure the company's financial stability by
   concluding a new restructuring plan. In addition to further restructuring
   measures, the legal options available against Unither arising from the
   sale of the Carragelose business and the assets of the Marinosolv platform
   are to be utilized.
   +++ End of ad-hoc announcement +++
    

   End of Inside Information

   ══════════════════════════════════════════════════════════════════════════

   16-Jul-2026 CET/CEST News transmitted by [3]EQS Group

   View original content: [4]EQS News

   ══════════════════════════════════════════════════════════════════════════

   Language:    English
   Company:     Marinomed Biotech AG
                Hovengasse 25
                2100 Korneuburg
                Austria
   Phone:       +43 2262 90300
   E-mail:      [email protected]
   Internet:    www.marinomed.com
   ISIN:        ATMARINOMED6
   WKN:         A2N9MM
   Listed:      Regulated Unofficial Market in Dusseldorf, Frankfurt, Munich,
                Stuttgart, Tradegate BSX; Vienna Stock Exchange (Official
                Market)
   LEI Code:    529900GN3B1EN80XF405
   EQS News ID: 2367244


    
   End of Announcement EQS News Service


   2367244  16-Jul-2026 CET/CEST

   https://nwr.eqs-cockpit.com/fncls2.ssx?application_id=2367244&application_name=news&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf

References

   Visible links
   1. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=2be925ac0334ae7b4f51fbaee4a6daf0&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
   2. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=f5d50dc7e8798b6eb177f7955e598e60&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
   3. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=f5d50dc7e8798b6eb177f7955e598e60&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
   4. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=b687579a860aa32349feba5e0c206854&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT |

print